Nabriva Therapeutics plc Annual Costs and Expenses in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Nabriva Therapeutics plc quarterly/annual Costs and Expenses history and growth rate from 2017 to 2022.
  • Nabriva Therapeutics plc Costs and Expenses for the quarter ending June 30, 2023 was $14.3M, a 27.2% decline year-over-year.
  • Nabriva Therapeutics plc Costs and Expenses for the twelve months ending June 30, 2023 was $83.6M, a 3.21% increase year-over-year.
  • Nabriva Therapeutics plc annual Costs and Expenses for 2022 was $92.4M, a 19.4% increase from 2021.
  • Nabriva Therapeutics plc annual Costs and Expenses for 2021 was $77.4M, a 8.81% increase from 2020.
  • Nabriva Therapeutics plc annual Costs and Expenses for 2020 was $71.2M, a 20% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $92.4M +$15M +19.4% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 $77.4M +$6.27M +8.81% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $71.2M -$17.8M -20% Jan 1, 2020 Dec 31, 2020 10-K 2023-04-17
2019 $89M -$35.1M -28.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 $124M +$44.9M +56.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 $79.1M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.